• FAQ
Prophase Logo
open menu
  • About Us
    • About Us
    • Management Team
  • Our Companies
    • Nebula Genomics
    • ProPhase Diagnostics
    • ProPhase Biopharma
    • Pharmaloz Manufacturing
    • TK Supplements
  • Investor Relations
    • Presentations
    • News & Events
      • Press Releases
      • Media Mentions
      • IR Calendar
      • Email Alerts
    • Company Info
      • Management Team
      • Contacts
      • FAQ
    • Financial Info
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
  • Contact Us
    • Corporate
    • Diagnostics
    • Pharmaloz
    • TKSupplements

Press Releases

Investors

Investors

  • Overview
  • Presentations
  • News & Events
    • Press Releases
    • Media Mentions
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • Media Mentions
  • IR Calendar
  • Email Alerts
May 04, 2023 8:30am EDT

ProPhase Labs to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 11, 2023 at 11:00 a.m. Eastern Time

May 03, 2023 8:30am EDT

ProPhase Labs’ Linebacker-1 Cancer Therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers, including lung and gastric cancers

Apr 28, 2023 8:30am EDT

ProPhase Labs CEO Ted Karkus Named One of Inc Magazine’s 10 Most Innovative Healthcare Leaders to Watch in 2023

Apr 25, 2023 8:30am EDT

ProPhase Labs Announces Launch of Redesigned Corporate Website

Apr 18, 2023 8:00am EDT

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023

Mar 28, 2023 8:00am EDT

ProPhase Labs Announces Record Financial Results for the year ended December 31, 2022

Mar 21, 2023 8:00am EDT

ProPhase Labs to Host 2022 Year End Financial Results Conference Call on Tuesday, March 28, 2023 at 11:00 a.m. Eastern Time

Mar 15, 2023 8:00am EDT

ProPhase Labs Announces New $6 Million Stock Repurchase Program

Mar 13, 2023 8:00am EDT

ProPhase Labs Announces Data Presentation for its BE-Smart Esophageal Cancer Test

Mar 01, 2023 8:00am EST

ProPhase Labs Announces Collaboration with mProbe, Inc. and Mayo Clinic for the Continuing Development of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …23
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Prophase Logo

© Copyright - ProPhase Labs, Inc.
All Rights Reserved.

  • About Us
  • Our Companies
  • Investor Relations
  • Contact Us
  • Site Map
  • Legal Notice
  • Accessibility